Product NDC: | 51079-971 |
Proprietary Name: | Fluoxetine |
Non Proprietary Name: | fluoxetine hydrochloride |
Active Ingredient(s): | 20 mg/1 & nbsp; fluoxetine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-971 |
Labeler Name: | UDL Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075207 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110711 |
Package NDC: | 51079-971-19 |
Package Description: | 25 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-971-19) > 1 CAPSULE in 1 BLISTER PACK (51079-971-17) |
NDC Code | 51079-971-19 |
Proprietary Name | Fluoxetine |
Package Description | 25 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-971-19) > 1 CAPSULE in 1 BLISTER PACK (51079-971-17) |
Product NDC | 51079-971 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fluoxetine hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110711 |
Marketing Category Name | ANDA |
Labeler Name | UDL Laboratories, Inc. |
Substance Name | FLUOXETINE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |